首页> 外国专利> HUMANIZED ANTI HUMAN EPIDEMIC GROWTH FACTOR RECEPTOR ANTIBODY AND ENCODING GENE AND APPLICATION THEREOF

HUMANIZED ANTI HUMAN EPIDEMIC GROWTH FACTOR RECEPTOR ANTIBODY AND ENCODING GENE AND APPLICATION THEREOF

机译:人源化抗人类流行病生长因子受体抗体和编码基因及其应用

摘要

Provided are a humanized anti-human epidemic growth factor receptor (EGFR) antibody and an encoding gene and an application thereof. According to the present invention, a single-chain antibody resisting the human EGFR is screened from a complete synthesis type single-chain human antibody library, and based on an obtained variable region gene sequence of the antibody, complete human monoclonal antibodies are constructed. The affinity of the antibody for the human EGFT is not less than InM, and the affinity of the mutant of the antibody for the human EGFR is not less than 10 nM. The antibody has good biological activity for inhibiting the tumor growth of the EGFR high-expressing cell A431 tumor-bearing model mouse.
机译:本发明提供了人源化抗人流行病生长因子受体(EGFR)抗体和编码基因及其应用。根据本发明,从完整的合成型单链人抗体文库中筛选抗人EGFR的单链抗体,并基于获得的抗体的可变区基因序列,构建完整的人单克隆抗体。抗体对人EGFT的亲和力不小于InM,并且抗体突变体对人EGFR的亲和力不小于10nM。该抗体具有良好的生物学活性,可抑制EGFR高表达细胞A431荷瘤模型小鼠的肿瘤生长。

著录项

  • 公开/公告号IN2015MN00976A

    专利类型

  • 公开/公告日2016-05-27

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN976/MUMNP/2015

  • 发明设计人 WANG SHUANG;SUN ZHIWEI;SUN JIURU;

    申请日2015-04-27

  • 分类号C07K16/28;C07K16/30;C12P21/08;C07K16/46;A61K47/48;C12N15/09;C07K19/00;C12N15/63;C12N5/10;C12N1/21;A61K45/00;A61K39/395;A61P29/00;C12N15/13;G01N33/53;C12N1/15;A61P35/00;C12N1/19;C12N15/10;A61P37/02;C07K1/22;

  • 国家 IN

  • 入库时间 2022-08-21 14:24:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号